GlassScriptPhysician profile
William C Scurry
NPI 1114144979
$19,065.86
in general payments reported to CMS, 2019-2025
20 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $63.36 · 2021: $172 · 2022: $270 · 2023: $230 · 2024: $324 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $670.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $17,785.62 | 2019-2021 | |
| Galderma Laboratories, L.P. | $206.11 | 2022-2025 | Dysport |
| Davol INC. | $203.16 | 2022-2024 | Arista Ah Flexitip |
| Abbvie INC. | $159.25 | 2024-2025 | |
| Allergan, INC. | $128.71 | 2022 | |
| Masimo Corporation | $112.30 | 2021-2025 | Set and Rainbow Set |
| Regeneron Healthcare Solutions, INC. | $59.43 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $55.97 | 2022 | |
| Intersect Ent, INC. | $52.81 | 2019-2020 | |
| Revance Therapeutics, INC. | $45.55 | 2025 | Daxxify |
| Genzyme Corporation | $45.16 | 2021 | |
| Organogenesis INC. | $45.04 | 2021 | |
| Optinose US, INC. | $29.13 | 2020 | |
| Lilly USA, LLC | $28.54 | 2022 | |
| Karl Storz Endoscopy-America | $27.57 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $23.17 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $17.88 | 2024 | Exparel |
| Alk-Abello, INC | $15.14 | 2021 | |
| Kaleo, INC. | $13.20 | 2021 | |
| Novartis Pharmaceuticals Corporation | $12.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Scurry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.